Navigation Links
Clot Buster Safe for Stroke Patients on Blood Thinners: Study
Date:3/14/2013

THURSDAY, March 14 (HealthDay News) -- There is little risk of dangerous brain bleeds when giving the clot-busting drug tPA to people suffering a stroke who have been taking certain types of blood thinners, a new study says.

Millions of Americans take aspirin or other blood thinners every day to reduce their risk of blood clots, which can lead to heart attack and stroke. If they suffer a stroke, medical emergency teams may be reluctant to give them tPA due to fears that the combination of drugs might cause dangerous brain bleeding.

Researchers at the University of Michigan Stroke Program, however, found that this fear is unfounded in many cases. They looked at data from more than 800 stroke patients who received tPA at 28 Michigan hospitals. Just less than half of them had been taking aspirin or the blood thinner drug Plavix (clopidogrel) before their stroke.

After they adjusted for various patient characteristics, the researchers found no significant difference in the rate of brain bleeding between patients who had been taking aspirin or Plavix and those who weren't taking any blood thinners.

The findings, published in the journal Academic Emergency Medicine, should help reassure medical staff and patients that tPA is safe to use in patients who have been taking aspirin or Plavix, the researchers said.

"This study, from a broad range of hospitals, provides solid evidence based on real-world use of tPA that physicians should not alter their decision-making based on aspirin or [Plavix] use when treating stroke patients with tPA," study author Dr. William Meurer, an assistant professor of emergency medicine at the University of Michigan Medical School, said in a university news release.

The researchers noted, however, that their study did not include patients taking more powerful blood thinners, such as warfarin (Coumadin), heparin, dabigatran (Pradaxa) or rivaroxaban (Xarelto). The use of tPA in patients taking these drugs needs much more study.

More information

The U.S. Agency for Healthcare Research and Quality has more about blood thinners.

-- Robert Preidt

SOURCES: University of Michigan Health System, news release, March 12, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Clot-Buster Drug May Still Be Best Stroke Treatment
2. Better stroke care, everywhere: NIH-funded study boosts local hospitals clotbuster use
3. Lice Tamers Brings FDA-Cleared LouseBuster™ Device to Suffolk County
4. Garbled text messages may be the only symptoms of stroke
5. UH Case Medical Center awarded highest certification as Comprehensive Stroke Center
6. Breakthrough Drug MW151 Emerges as a Potential Competitor to Perispinally Administered Etanercept Inducing Rapid Recovery of Functions Lost to Alzheimer’s, Stroke and TBI
7. Stroke risk in elderly treated with antipsychotics is newly linked to specific drug actions
8. Obese New Mothers May Have Higher Heart Attack, Stroke Risk
9. Minocycline Enhances the Efficacy of Perispinal Enbrel in Traumatic Brain Injury Treatment as well as Stroke Treatment and Alzheimer’s Treatment
10. Walking Program Helps Stroke Survivors Get On With Life
11. Eye-Tracking Tool Might Quickly Spot Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clot Buster Safe for Stroke Patients on Blood Thinners: Study
(Date:4/28/2016)... (PRWEB) , ... April 29, 2016 , ... Monthly subscription ... products on the market. They recently reviewed the ZEN BOX , the aromatherapy ... are two single essential oils (like lavender or frankincense) and one Zen Blend (like ...
(Date:4/28/2016)... ... April 28, 2016 , ... Sanford Health’s ... week. A group of researchers and leaders from Sanford Health were selected to ... and Its Cultural Impact ” and receive the 2016 Pontifical Key Innovation Award ...
(Date:4/28/2016)... ... 2016 , ... CastCoverz!, America’s #1 trusted brand for cast ... waterproof cast protector . As the largest one-stop, orthopedic shop, CastCoverz! offers ... night, weatherproof and waterproof covers for most orthopedic devices, including but not limited ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... announces today the open availability of a new CDISC standard, Clinical Trial ... registering clinical trials. This innovative standard will make it possible to build ...
(Date:4/28/2016)... ... April 28, 2016 , ... Trinity Health, one of ... leading force in the fight to reduce tobacco use and its deadly toll, ... help reduce tobacco use. The initiative brings together two organizations committed to achieving ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
(Date:4/27/2016)... 2016 At the Sachs CEO ... a Phase 2 clinical study of its lead drug ... cochlear implantation (CI) surgery. This large, placebo-controlled, double-blind, phase ... Germany and France . ... the time of surgery. "Despite advances in cochlear implant ...
(Date:4/26/2016)... 26, 2016 US demand for infection ... 4.9 percent annually to $27.6 billion in 2020.  ... to decrease rates of healthcare-associated infections (HAIs) will ... and services.  Although declining, the overall rate of ... levels set by the CDC.  Recent statistics indicate ...
Breaking Medicine Technology: